Rhabdomyolysis following administration of cyclophosphamide: A case report in a BMT recipient

Bone Marrow Transplantation

Volumn 17, Issue 6, 1996, Pages 1167-1169

  Tabata, N ^a   Tanaka, R ^a,b   Suga, S ^a   Mitani, Y ^a   Nakano, T ^a   Ido, M ^a   Azuma, E ^a   Ito, M ^a   Hamazaki, M ^c   Shiraishi, T ^a   Sakurai, M ^a  

^a MIE UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c SHIZUOKA CHILDREN'S HOSPITAL   (Japan)

Author keywords

BMT; Cyclophosphamide; Rhabdomyolysis

Indexed keywords

CYCLOPHOSPHAMIDE;

ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CASE REPORT; CHILD; FEMALE; HEART MUSCLE NECROSIS; HUMAN; PRIORITY JOURNAL; RHABDOMYOLYSIS; SCHOOL CHILD;

BONE MARROW TRANSPLANTATION; CHILD; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RHABDOMYOLYSIS; TRANSPLANTATION CONDITIONING;

EID: 8944248810     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Storb B. Marrow transplantation for aplastic anemia. In: Forman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific Publications: Cambridge, 1994, pp 583-594.
2. Wagner JE, Yeager AM, Beschorner WE. Pathology of bone marrow transplantation. In: Johnson FL, Pochedly C (eds). Bone Marrow Transplantation in Children. Raven Press: New York, 1990, pp 141-164.
3. Climie ARW. Diseases of skeletal muscle. In: Kissane JM (ed). Anderson's Pathology. Mosby: St Louis, 1985, pp 1853-1869.
4. Volin L, Järventie G, Ruutu T. Fetal rhabdomyolysis as a complication of bone marrow transplantation. Bone Marrow Transplant 1990; 6: 59-60.
5. Maruyama F, Miyazaki H, Ezaki K et al. Severe rhabdomyolysis as a complication of peripheral blood stem cell transplantation. Bone Marrow Transplant 1994; 14: 481-482.
6. Friedman HS, Colin OM, Aisaka K et al. Glutathione protects cardiac and skeletal muscle from cyclophosphamide-induced toxicity. Cancer Res 1990; 50: 2455-2462.
7. Meister A. Selective modification of glutathione metabolism. Science 1983; 220: 471-477.
8. Draeger U, Peter G, Hohorst HJ. Deactivation of cyclophosphamide (NSC-26271) metabolites by sulphydryl compounds. Cancer Treat Rep 1976; 60: 355-359.